B-Cellular_component	0	11	Subcellular	Subcellular	JJ	B-NP
O	12	24	localisation	localisation	NN	I-NP
O	25	27	of	of	IN	B-PP
O	28	31	BAG	BAG	NN	B-NP
O	31	32	-	-	HYPH	B-NP
O	32	33	1	1	CD	I-NP
O	34	37	and	and	CC	O
O	38	41	its	its	PRP$	B-NP
O	42	52	regulation	regulation	NN	I-NP
O	53	55	of	of	IN	B-PP
O	56	63	vitamin	vitamin	NN	B-NP
O	64	65	D	D	NN	I-NP
O	66	74	receptor	receptor	NN	I-NP
O	74	75	-	-	HYPH	B-NP
O	75	83	mediated	mediate	VBN	I-NP
O	84	99	transactivation	transactivation	NN	I-NP
O	100	103	and	and	CC	I-NP
O	104	114	involucrin	involucrin	NN	I-NP
O	115	125	expression	expression	NN	I-NP
O	126	128	in	in	IN	B-PP
B-Cell	129	133	oral	oral	JJ	B-NP
I-Cell	134	147	keratinocytes	keratinocyte	NNS	I-NP
O	147	148	:	:	:	O
O	149	161	implications	implication	NNS	B-NP
O	162	165	for	for	IN	B-PP
B-Organism_subdivision	166	170	oral	oral	JJ	B-NP
O	171	185	carcinogenesis	carcinogenesis	NN	I-NP
O	185	186	.	.	.	O

O	188	190	In	In	IN	B-PP
B-Cancer	191	195	oral	oral	JJ	B-NP
I-Cancer	196	203	cancers	cancer	NNS	I-NP
O	203	204	,	,	,	O
B-Organism_substance	205	216	cytoplasmic	cytoplasmic	JJ	B-NP
O	217	220	BAG	BAG	NN	I-NP
O	220	221	-	-	HYPH	B-NP
O	221	222	1	1	CD	I-NP
O	223	237	overexpression	overexpression	NN	I-NP
O	238	240	is	be	VBZ	B-VP
O	241	242	a	a	DT	B-NP
O	243	249	marker	marker	NN	I-NP
O	250	252	of	of	IN	B-PP
O	253	257	poor	poor	JJ	B-NP
O	258	267	prognosis	prognosis	NN	I-NP
O	267	268	.	.	.	O

O	269	272	BAG	BAG	NN	B-NP
O	272	273	-	-	HYPH	B-NP
O	273	274	1	1	CD	I-NP
O	275	284	regulates	regulate	VBZ	B-VP
B-Cell	285	293	cellular	cellular	JJ	B-NP
O	294	300	growth	growth	NN	I-NP
O	300	301	,	,	,	O
O	302	317	differentiation	differentiation	NN	B-NP
O	318	321	and	and	CC	O
O	322	330	survival	survival	NN	B-NP
O	331	338	through	through	IN	B-PP
O	339	351	interactions	interaction	NNS	B-NP
O	352	356	with	with	IN	B-PP
O	357	364	diverse	diverse	JJ	B-NP
O	365	373	proteins	protein	NNS	I-NP
O	373	374	,	,	,	O
O	375	384	including	include	VBG	B-PP
O	385	388	the	the	DT	B-NP
O	389	396	vitamin	vitamin	NN	I-NP
O	397	398	D	D	NN	I-NP
O	399	407	receptor	receptor	NN	I-NP
O	408	409	(	(	(	O
O	409	412	VDR	VDR	NN	B-NP
O	412	413	)	)	)	O
O	413	414	,	,	,	O
O	415	416	a	a	DT	B-NP
O	417	420	key	key	JJ	I-NP
O	421	430	regulator	regulator	NN	I-NP
O	431	433	of	of	IN	B-PP
B-Cell	434	446	keratinocyte	keratinocyte	NN	B-NP
O	447	453	growth	growth	NN	B-NP
O	454	457	and	and	CC	O
O	458	473	differentiation	differentiation	NN	B-NP
O	473	474	.	.	.	O

O	475	478	BAG	BAG	NN	B-NP
O	478	479	-	-	HYPH	B-NP
O	479	480	1	1	CD	I-NP
O	481	483	is	be	VBZ	B-VP
O	484	493	expressed	express	VBN	I-VP
O	494	506	ubiquitously	ubiquitously	RB	B-ADVP
O	507	509	in	in	IN	B-PP
O	510	515	human	human	JJ	B-NP
B-Cell	516	521	cells	cell	NNS	I-NP
O	522	524	as	as	IN	B-PP
O	525	530	three	three	CD	B-NP
O	531	536	major	major	JJ	I-NP
O	537	545	isoforms	isoform	NNS	I-NP
O	546	548	of	of	IN	B-PP
O	549	551	50	50	CD	B-NP
O	552	555	kDa	kDa	NN	I-NP
O	556	557	(	(	(	O
O	557	560	BAG	BAG	NN	B-NP
O	560	561	-	-	HYPH	B-NP
O	561	563	1L	1L	NN	I-NP
O	563	564	)	)	)	O
O	564	565	,	,	,	O
O	566	568	46	46	CD	B-NP
O	569	572	kDa	kDa	NN	I-NP
O	573	574	(	(	(	O
O	574	577	BAG	BAG	NN	B-NP
O	577	578	-	-	HYPH	B-NP
O	578	580	1M	1M	NN	I-NP
O	580	581	)	)	)	O
O	582	585	and	and	CC	O
O	586	588	36	36	CD	B-NP
O	589	592	kDa	kDa	NN	I-NP
O	593	594	(	(	(	O
O	594	597	BAG	BAG	NN	B-NP
O	597	598	-	-	HYPH	B-NP
O	598	600	1S	1S	NN	I-NP
O	600	601	)	)	)	O
O	602	606	from	from	IN	B-PP
O	607	608	a	a	DT	B-NP
O	609	615	single	single	JJ	I-NP
O	616	620	mRNA	mRNA	NN	I-NP
O	620	621	.	.	.	O

O	622	624	In	In	IN	B-PP
B-Cell	625	629	oral	oral	JJ	B-NP
I-Cell	630	643	keratinocytes	keratinocyte	NNS	I-NP
O	644	647	BAG	BAG	NN	I-NP
O	647	648	-	-	HYPH	B-NP
O	648	650	1L	1L	NN	I-NP
O	650	651	,	,	,	O
O	652	655	but	but	CC	O
O	656	659	not	not	RB	O
O	660	663	BAG	BAG	NN	B-NP
O	663	664	-	-	HYPH	B-NP
O	664	666	1M	1M	NN	I-NP
O	667	670	and	and	CC	I-NP
O	671	674	BAG	BAG	NN	I-NP
O	674	675	-	-	HYPH	B-NP
O	675	677	1S	1S	NN	I-NP
O	677	678	,	,	,	O
O	679	687	enhanced	enhance	VBD	B-VP
O	688	691	VDR	VDR	NN	B-NP
O	692	707	transactivation	transactivation	NN	I-NP
O	708	710	in	in	IN	B-PP
O	711	719	response	response	NN	I-PP
O	720	722	to	to	TO	I-PP
O	723	729	1alpha	1alpha	NN	B-NP
O	729	730	,	,	,	O
O	730	732	25	25	CD	B-NP
O	732	733	-	-	HYPH	I-NP
O	733	749	dihydroxyvitamin	dihydroxyvitamin	NN	I-NP
O	750	752	D3	D3	NN	I-NP
O	752	753	.	.	.	O

O	754	757	BAG	BAG	NN	B-NP
O	757	758	-	-	HYPH	O
O	758	760	1L	1L	NN	B-NP
O	761	764	was	be	VBD	B-VP
B-Organism_substance	765	778	nucleoplasmic	nucleoplasmic	JJ	B-ADJP
O	779	782	and	and	CC	I-ADJP
B-Cellular_component	783	792	nucleolar	nucleolar	JJ	I-ADJP
O	792	793	,	,	,	O
O	794	801	whereas	whereas	IN	O
O	802	805	BAG	BAG	NN	B-NP
O	805	806	-	-	HYPH	I-NP
O	806	808	1S	1S	NN	I-NP
O	809	812	and	and	CC	I-NP
O	813	816	BAG	BAG	NN	I-NP
O	816	817	-	-	HYPH	O
O	817	819	1M	1M	NN	B-NP
O	820	824	were	be	VBD	B-VP
B-Organism_substance	825	836	cytoplasmic	cytoplasmic	JJ	B-ADJP
O	837	840	and	and	CC	I-ADJP
B-Organism_substance	841	854	nucleoplasmic	nucleoplasmic	JJ	I-ADJP
O	855	857	in	in	IN	B-PP
O	858	870	localisation	localisation	NN	B-NP
O	870	871	.	.	.	O

O	872	878	Having	Have	VBG	B-VP
O	879	889	identified	identify	VBN	I-VP
O	890	893	the	the	DT	B-NP
B-Cellular_component	894	903	nucleolar	nucleolar	JJ	I-NP
O	904	916	localisation	localisation	NN	I-NP
O	917	925	sequence	sequence	NN	I-NP
O	926	928	in	in	IN	B-PP
O	929	932	BAG	BAG	NN	B-NP
O	932	933	-	-	HYPH	O
O	933	935	1L	1L	NN	B-NP
O	935	936	,	,	,	O
O	937	939	we	we	PRP	B-NP
O	940	946	showed	show	VBD	B-VP
O	947	951	that	that	IN	B-SBAR
O	952	960	mutation	mutation	NN	B-NP
O	961	963	of	of	IN	B-PP
O	964	968	this	this	DT	B-NP
O	969	977	sequence	sequence	NN	I-NP
O	978	981	did	do	VBD	B-VP
O	982	985	not	not	RB	I-VP
O	986	993	prevent	prevent	VB	I-VP
O	994	997	BAG	BAG	NN	B-NP
O	997	998	-	-	HYPH	B-NP
O	998	1000	1L	1L	NN	I-NP
O	1001	1005	from	from	IN	B-PP
O	1006	1018	potentiating	potentiate	VBG	B-VP
O	1019	1022	VDR	VDR	NN	B-NP
O	1023	1031	activity	activity	NN	I-NP
O	1031	1032	.	.	.	O

O	1033	1036	BAG	BAG	NN	B-NP
O	1036	1037	-	-	HYPH	I-NP
O	1037	1039	1L	1L	NN	I-NP
O	1040	1044	also	also	RB	B-ADVP
O	1045	1056	potentiated	potentiate	VBD	B-VP
O	1057	1072	transactivation	transactivation	NN	B-NP
O	1073	1075	of	of	IN	B-PP
O	1076	1081	known	know	VBN	B-NP
O	1082	1089	vitamin	vitamin	NN	I-NP
O	1089	1090	-	-	HYPH	B-NP
O	1090	1091	D	D	NN	I-NP
O	1091	1092	-	-	HYPH	I-NP
O	1092	1102	responsive	responsive	JJ	I-NP
O	1103	1107	gene	gene	NN	I-NP
O	1108	1117	promoters	promoter	NNS	I-NP
O	1117	1118	,	,	,	O
O	1119	1130	osteocalcin	osteocalcin	NN	B-NP
O	1131	1134	and	and	CC	O
O	1135	1137	24	24	CD	B-NP
O	1137	1138	-	-	HYPH	I-NP
O	1138	1149	hydroxylase	hydroxylase	NN	I-NP
O	1149	1150	,	,	,	O
O	1151	1154	and	and	CC	O
O	1155	1163	enhanced	enhance	VBN	B-NP
O	1164	1167	VDR	VDR	NN	I-NP
O	1167	1168	-	-	HYPH	B-NP
O	1168	1177	dependent	dependent	JJ	I-NP
O	1178	1191	transcription	transcription	NN	I-NP
O	1192	1195	and	and	CC	I-NP
O	1196	1203	protein	protein	NN	I-NP
O	1204	1214	expression	expression	NN	I-NP
O	1215	1217	of	of	IN	B-PP
O	1218	1221	the	the	DT	B-NP
B-Cell	1222	1234	keratinocyte	keratinocyte	NN	I-NP
O	1235	1250	differentiation	differentiation	NN	I-NP
O	1251	1257	marker	marker	NN	I-NP
O	1257	1258	,	,	,	O
O	1259	1269	involucrin	involucrin	NN	B-NP
O	1269	1270	.	.	.	O

O	1271	1276	These	These	DT	B-NP
O	1277	1284	results	result	NNS	I-NP
O	1285	1296	demonstrate	demonstrate	VBP	B-VP
O	1297	1307	endogenous	endogenous	JJ	B-NP
O	1308	1312	gene	gene	NN	I-NP
O	1313	1323	regulation	regulation	NN	I-NP
O	1324	1326	by	by	IN	B-PP
O	1327	1330	BAG	BAG	NN	B-NP
O	1330	1331	-	-	HYPH	O
O	1331	1333	1L	1L	NN	B-NP
O	1334	1336	by	by	IN	B-PP
O	1337	1349	potentiating	potentiate	VBG	B-VP
O	1350	1357	nuclear	nuclear	JJ	B-NP
O	1358	1365	hormone	hormone	NN	I-NP
O	1366	1374	receptor	receptor	NN	I-NP
O	1375	1383	function	function	NN	I-NP
O	1384	1387	and	and	CC	O
O	1388	1395	suggest	suggest	VBP	B-VP
O	1396	1397	a	a	DT	B-NP
O	1398	1402	role	role	NN	I-NP
O	1403	1406	for	for	IN	B-PP
O	1407	1410	BAG	BAG	NN	B-NP
O	1410	1411	-	-	HYPH	B-NP
O	1411	1413	1L	1L	NN	I-NP
O	1414	1416	in	in	IN	B-PP
O	1417	1419	24	24	CD	B-NP
O	1419	1420	-	-	HYPH	I-NP
O	1420	1431	hydroxylase	hydroxylase	NN	I-NP
O	1432	1442	regulation	regulation	NN	I-NP
O	1443	1445	of	of	IN	B-PP
O	1446	1453	vitamin	vitamin	NN	B-NP
O	1454	1455	D	D	NN	I-NP
O	1456	1466	metabolism	metabolism	NN	I-NP
O	1467	1470	and	and	CC	O
O	1471	1474	the	the	DT	B-NP
B-Cell	1475	1483	cellular	cellular	JJ	I-NP
O	1484	1492	response	response	NN	I-NP
O	1493	1495	of	of	IN	B-PP
B-Cell	1496	1500	oral	oral	JJ	B-NP
I-Cell	1501	1514	keratinocytes	keratinocyte	NNS	I-NP
O	1515	1517	to	to	TO	B-PP
O	1518	1524	1alpha	1alpha	NN	B-NP
O	1524	1525	,	,	,	O
O	1525	1527	25	25	CD	B-NP
O	1527	1528	-	-	HYPH	I-NP
O	1528	1544	dihydroxyvitamin	dihydroxyvitamin	NN	I-NP
O	1545	1547	D3	D3	NN	I-NP
O	1547	1548	.	.	.	O

O	1549	1551	By	By	IN	B-PP
O	1552	1560	contrast	contrast	NN	B-NP
O	1561	1563	to	to	TO	B-PP
O	1564	1567	the	the	DT	B-NP
B-Organism_substance	1568	1579	cytoplasmic	cytoplasmic	JJ	I-NP
O	1580	1583	BAG	BAG	NN	I-NP
O	1583	1584	-	-	HYPH	B-NP
O	1584	1585	1	1	CD	I-NP
O	1586	1594	isoforms	isoform	NNS	I-NP
O	1594	1595	,	,	,	O
O	1596	1599	BAG	BAG	NN	B-NP
O	1599	1600	-	-	HYPH	I-NP
O	1600	1602	1L	1L	NN	I-NP
O	1603	1606	may	may	MD	B-VP
O	1607	1610	act	act	VB	I-VP
O	1611	1613	to	to	TO	I-VP
O	1614	1622	suppress	suppress	VB	I-VP
O	1623	1636	tumorigenesis	tumorigenesis	NN	B-NP
O	1636	1637	.	.	.	O

